64
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Potentiation of murine innate immunity by α-galacturonosyl-type glycosphingolipids isolated from Sphingomonas yanoikuyae and S. terrae

, , , &
Pages 363-369 | Received 18 Jul 2008, Accepted 25 Aug 2008, Published online: 11 May 2009
 

Abstract

Glycosphingolipids (GSLs) are components of the outer membrane of Sphingomonas species, commonly classified into two types, α-glucuronosyl ceramide (α-GlcACer) and α-galacturonosyl ceramide (α-GalACer), respectively. GSL-7 from S. yanoikuyae and GSL-13 from S. terrae, with α-GalACer-type structure, possess dihydrosphingosine but with a different ratio of C21cyclopropane to C20:1, while other parts remain similar. We therefore examined if this difference in the ratio of C21cyclopropane to C20:1 in the two ceramides may influence activation of, not only invariant natural killer T (iNKT) cells, but also other cells involved in innate immunity. GSL-7 with a large proportion of C21cyclopropane induced stronger activation of iNKT cells, natural killer cells, dendritic cells, and macrophages than GSL-13 with a large proportion of C20:1. The results show that a higher ratio of C21cyclopropane to C20:1 in the dihydrosphingosine molecule allows a more optimal activation of iNKT cells and other cell types.

Acknowledgments

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.